ECO Animal Health Group plc (EAH.L) announced that the European Commission has adopted a decision granting EU marketing authorisation for ECOVAXXIN MS, the company's poultry vaccine against Mycoplasma synoviae. The company noted that the MA has been issued over a month earlier than anticipated following the Committee for Medicinal Products for Veterinary Use's Positive Opinion in November 2025.
The company said it will issue an update to the market in early 2026 to provide further details on its plans for the EU commercial launch of ECOVAXXIN MS.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.